Form 4: Lexicon Pharmaceuticals Executive Wendy McDermott Reports Stock Transactions
SEC Form 4 Filing
Wendy McDermott, SVP of Human Resources at Lexicon Pharmaceuticals, reports the vesting and subsequent disposal of restricted stock units to cover tax obligations.
Summary
- Wendy McDermott, SVP of Human Resources at Lexicon Pharmaceuticals, filed a Form 4 detailing changes in beneficial ownership.
- On February 28, 2025, McDermott vested restricted stock units and received shares of common stock.
- A portion of the shares were withheld by the company to satisfy tax obligations.
- McDermott now directly owns 121,646 shares of Lexicon Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of transaction: vesting of restricted stock units and share withholding for taxes. |
| 03/03/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.